Partner news
News
Partner news
Protagonist Therapeutics Expands Series B Financing to $18 Million with Addition of $4 Million from Pharmstandard
Read full storyPartner news
Five Prime Therapeutics Announces Pricing of Initial Public Offering
Read full storyPartner news
Genocea Reports Positive Initial Phase 1/2a Results for Gen-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (Hsv-2), at ICAAC 2013
Read full storyPartner news
First Patient Enrolls in U.S. Salus Trial Evaluating Direct Flow Medical® Transcatheter Aortic Heart Valve System
Read full storyPartner news
Results of First Multi-Center Trial of NovoTTFTM Therapy in Combination with Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) Published in Lung Cancer
Read full storyPartner news
Galien Foundation Selects NovoTTF™ Therapy as a Finalist for the 2013 Prix Galien USA Award
Read full storyPartner news